U.S., June 19 -- ClinicalTrials.gov registry received information related to the study (NCT07655804) titled 'Subcutaneous Calcitonin in Acute Herpes Zoster' on June 13.
Brief Summary: This prospective randomized controlled study will be conducted to evaluate the effect of adding calcitonin to the standard treatment protocol in patients with acute herpes zoster infection.
Study Start Date: July 01
Study Type: INTERVENTIONAL
Condition:
Calcitonin
Subcutaneous
Acute Herpes Zoster
Intervention:
DRUG: Calcitonin
patients will receive subcutaneous salmon calcitonin 100 IU (ampoule = 1 ml) daily for three weeks
OTHER: Saline
patients will receive subcutaneous saline (1 ml) daily for three weeks.
Recruitment Status: NOT_YET_RECRUITING
S...